الرئيسية » أرشيف الكاتب: Catherine Skari (صفحة 9)

أرشيف الكاتب: Catherine Skari

Gene Editing

CRISPR gene editing   Update: 25 November 2019 CRISPR Therapeutics and Vertex Pharmaceuticals announced positive, interim data from the first two patients with severe haemoglobinopathies treated with the investigational CRISPR/Cas9 gene-editing therapy CTX001. 1 patient with transfusion-dependent beta-thalassaemia (TDT) received CTX001 in the first quarter of 2019 and data for ...

أكمل القراءة »

Hepcidin

Hepcidin trials – TRANSCEND   Update: 25 November 2019 No update available.   Update: 27 September 2019 No update available   Update: 30 July 2019 No update available.   Update: 30 May 2019 No update available.   Update: 01 February 2019 Hepcidin is a hormone that performs various functions related ...

أكمل القراءة »

Improving safety of blood transfusion

    INTERCEPT-treated RBCs   Update: 25 November 2019 No update available   Update: 27 September 2019 No update available   Update: 30 July 2019 No update available.   Update: 30 May 2019 No update available.   Update: 01 February 2019 The SPARC study was a randomized, double blinded cross-over ...

أكمل القراءة »

Mr Abdul Baset Mohd Merdas

Mr. Abdel Basset Mohamed Merdas was born in the United Arab Emirates in Dubai in 1960, and holds a Bachelor Degree in Business Administration. He worked for the Dubai Government from 1989 until 2006. He is one of the founders of the Emirates Thalassemia Society (ETS), and played a major ...

أكمل القراءة »